NCT01345357
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Teva Investigational Site 3 Brussels, Belgium
- Teva Investigational Site 1 Nantes, France
- Teva Investigational Site 2 Villejuif, France